Quarterly report pursuant to Section 13 or 15(d)

Sponsored Research and Clinical Trial Agreements (Tables)

v3.20.2
Sponsored Research and Clinical Trial Agreements (Tables)
6 Months Ended
Jun. 30, 2020
Mustang [Member]  
Schedule of research and development for sponsored research and clinical trial agreements

For the three and six months ended June 30, 2020 and 2019, Mustang recorded the following expense in research and development for sponsored research and clinical trial agreements:

For the Three Months Ended June 30, 

For the Six Months Ended June 30, 

($ in thousands)

    

2020

    

2019

    

2020

    

2019

COH CAR T

$

$

500

$

500

$

1,000

COH – CD123 (MB-102)

 

65

 

456

 

296

 

759

COH - IL13Rα2 (MB-101)

 

234

 

225

 

326

 

567

COH – Manufacturing

 

 

115

 

 

229

COH - CS1 (MB-104)

770

770

Beth Israel Deaconess Medical Center - CRISPR

69

St. Jude – XSCID (MB-107)

1,558

1,558

Fred Hutch - CD20 (MB-106)

189

374

716

641

Total

$

2,816

$

1,670

$

4,166

$

3,265